翻訳と辞書
Words near each other
・ Abchak
・ Abchalagi
・ Abchanchu
・ Abchi
・ Abcho
・ Abchuiyeh
・ ABCI
・ Abciximab
・ Abckiria
・ ABCL
・ ABCmouse.com Early Learning Academy
・ ABCN
・ ABCO Foods
・ ABCO Industries Lunenburg Shipyard
・ ABCO Transportation
Abcodia
・ Abcott
・ Abcoude
・ Abcoude railway station
・ Abcoude-Proostdij
・ Abcoulomb
・ ABCP
・ ABCR
・ ABCS
・ ABCs (song)
・ ABCs of Attraction
・ ABCs of Death 2
・ ABCS Tournament
・ Abcsearch
・ ABCT


Dictionary Lists
翻訳と辞書 辞書検索 [ 開発暫定版 ]
スポンサード リンク

Abcodia : ウィキペディア英語版
Abcodia

Abcodia is a specialist company that focuses on biomarkers for cancer screening. Its aim is to discover and validate biomarkers that can be used for the early detection of cancer. Early detection provides more treatment options and has been shown to improve survival rates. Working in collaboration with academics, technology partners and commercial diagnostic partners, Abcodia aims to dramatically improve the way cancer is detected and managed.
== History ==

Abcodia is a spin-out from University College London and was founded in 2010. UCL granted Abcodia the exclusive commercialisation rights to a serum collection created by clinical scientists at the Institute for Women's Health at UCL. The serum biobank was formed as part of the UK Collaborative Trial of Ovarian Cancer Screening UKCTOCS, which was led by Professor Ian Jacobs and Professor Usha Menon. From 2001 to 2005, more than 202,000 women were randomly recruited onto the trial, all of whom provided a sample of blood on entry. Around 50,000 of these volunteers continued to provide samples annually until the end of 2011. All samples are stored in liquid nitrogen.
The biobank now contains more than 500,000 samples, 350,000 of which are longitudinal, i.e. they were taken from the same person over several years. The UCL team also created a valuable database of phenotypic, demographic and disease incidence for each volunteer. It shows that many volunteers who were originally healthy when they entered the trial have gone on to develop cancer or other debilitating disease.
On 6 June 2013 Abcodia announced a major collaboration with Cancer Research UK and its commercial arm, Cancer Research Technology, to develop new blood tests to detect a range of cancers when they are still at a very early stage. The strategic alliance will focus on biomarkers to detect cancers before patients develop symptoms, concentrating on cancers which currently have limited screening tests available, such as non-small cell lung cancer. Abcodia and CRT will jointly commercialise any biomarkers discovered during the collaboration.

抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)
ウィキペディアで「Abcodia」の詳細全文を読む



スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース

Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.